ALB

Albemarle Corporation
Specialty Chemicals · Materials · as of 2026-10-05
Last close
$104.37
-0.2% on the session
1-year return
+20.5%
-39.3% over six months
Volatility
57.3%
annualized, trailing year
Max drawdown
-51.3%
worst peak to trough, 1y
What the numbers say

Albemarle Corporation is a specialty chemicals name in the materials sector. Over the past year it returned +20.5%, against -18.8% over three months and -20.8% over one. It trades 32.4% below its 200-day average, so recent moves have not repaired the longer downtrend. Annualized volatility of 57.3% is very high, position sizing matters more here than the ranking does.

Its worst peak-to-trough decline over the year was -51.3%, and it has traded a median $264M a day, the figure that decides whether a position can actually be entered and exited at posted prices. Its daily moves correlate 0.34 with the S&P 500 proxy, so it has been moving substantially on its own.

Where it ranks
Within Materials#19 of 25
Stronger than 25% of its sector on the momentum profile
Across the whole index#467 of 496

How ALB scores on all four profiles

Its standing on steadiness, defensiveness and rebound, plus the factor-by-factor breakdown behind each score, and its closest and least-correlated peers among 5 others in Specialty Chemicals.

Start a free 7-day trial
Full metrics
1 day-0.2%
1 week-2.8%
1 month-20.8%
3 months-18.8%
6 months-39.3%
1 year+20.5%
12-1 momentum+52.1%
Volatility (1y, annualized)57.3%
Max drawdown (1y)-51.3%
Distance vs 200-day average-32.4%
Return per unit of risk0.36
Median daily dollar volume$264M
Free newsletter

Get ALB when it shows up in a ranking

Two editions a weekday, free, ranked lists built from this same data, on whatever the market is talking about.

Everything on this page is computed from daily adjusted closing prices. It contains no earnings, balance-sheet, guidance or ownership data, and it is not a valuation. Nothing here is tailored to your circumstances or a recommendation to buy or sell. Past performance does not predict future results.